Risk factors
Kodiak Sciences (KOD) risk factors
Item 1A of every Kodiak Sciences Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors93 risks7 new1 dropped10 reworded
Kodiak highlights new clinical pipeline updates for tarcocimab, KSI-501, and KSI-101. International trade policy risks and generative AI data risks are added. Clinical trial outcome disclosures and regulatory compliance updates are reworded.
Filed Mar 31, 2026 - FY2024 10-K risk factors87 risks
Kodiak Sciences is a clinical-stage biopharmaceutical company with no approved products and a history of net losses.
Filed Mar 27, 2025